Desq Long
Sign in

Company

10x Genomics, Inc.

TXG · CIK 0001770787

SEC FORM 4
$78,228.40

10x Genomics, Inc. (TXG)

Sale of 1,000 shares at $78.2284 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000421 · filed 2026-09-24 · View filing →

SEC FORM 4
$159,239.00

10x Genomics, Inc. (TXG)

Sale of 2,000 shares at $79.6195 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000421 · filed 2026-09-24 · View filing →

SEC FORM 4
$752,400.69

10x Genomics, Inc. (TXG)

Sale of 9,300 shares at $80.9033 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000421 · filed 2026-09-24 · View filing →

SEC FORM 4
$810,071.46

10x Genomics, Inc. (TXG)

Sale of 9,900 shares at $81.8254 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000421 · filed 2026-09-24 · View filing →

SEC FORM 4
$230,622.00

10x Genomics, Inc. (TXG)

Sale of 2,800 shares at $82.3650 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000421 · filed 2026-09-24 · View filing →

SEC FORM 4
$22,833.20

10x Genomics, Inc. (TXG)

Sale of 292 shares at $78.1959 per share.

Reporting Person SULIMAN SHEHNAAZ · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000422 · filed 2026-09-24 · View filing →

SEC FORM 4
$48,820.00

10x Genomics, Inc. (TXG)

Sale of 614 shares at $79.5114 per share.

Reporting Person SULIMAN SHEHNAAZ · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000422 · filed 2026-09-24 · View filing →

SEC FORM 4
$107,081.73

10x Genomics, Inc. (TXG)

Sale of 1,325 shares at $80.8164 per share.

Reporting Person SULIMAN SHEHNAAZ · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000422 · filed 2026-09-24 · View filing →

SEC FORM 4
$185,390.67

10x Genomics, Inc. (TXG)

Sale of 2,270 shares at $81.6699 per share.

Reporting Person SULIMAN SHEHNAAZ · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000422 · filed 2026-09-24 · View filing →

SEC FORM 4
$100,542.25

10x Genomics, Inc. (TXG)

Sale of 1,222 shares at $82.2768 per share.

Reporting Person SULIMAN SHEHNAAZ · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001610717-26-000422 · filed 2026-09-24 · View filing →

SEC FORM 4
$76,794.94

10x Genomics, Inc. (TXG)

Sale of 1,206 shares at $63.6774 per share.

Reporting Person Taich Adam · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001610717-26-000414 · filed 2026-09-11 · View filing →

SEC FORM 4
$2,021,125.25

10x Genomics, Inc. (TXG)

Sale of 31,428 shares at $64.3097 per share.

Reporting Person Taich Adam · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001610717-26-000414 · filed 2026-09-11 · View filing →

SEC FORM 4
$897,550.28

10x Genomics, Inc. (TXG)

Sale of 13,754 shares at $65.2574 per share.

Reporting Person Taich Adam · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001610717-26-000414 · filed 2026-09-11 · View filing →

SEC FORM 4
$425,333.19

10x Genomics, Inc. (TXG)

Sale of 7,012 shares at $60.6579 per share.

Reporting Person STUELPNAGEL JOHN R · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001610717-26-000405 · filed 2026-09-08 · View filing →

SEC FORM 4
$423,205.27

10x Genomics, Inc. (TXG)

Sale of 6,814 shares at $62.1082 per share.

Reporting Person STUELPNAGEL JOHN R · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001610717-26-000405 · filed 2026-09-08 · View filing →

SEC FORM 4
$386,533.15

10x Genomics, Inc. (TXG)

Sale of 6,174 shares at $62.6066 per share.

Reporting Person STUELPNAGEL JOHN R · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001610717-26-000405 · filed 2026-09-08 · View filing →

SEC FORM 4
$220,580.15

10x Genomics, Inc. (TXG)

Sale of 3,500 shares at $63.0229 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001610717-26-000393 · filed 2026-08-28 · View filing →

SEC FORM 4
$415,465.34

10x Genomics, Inc. (TXG)

Sale of 6,494 shares at $63.9768 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001610717-26-000393 · filed 2026-08-28 · View filing →

SEC FORM 4
$31,855.28

10x Genomics, Inc. (TXG)

Sale of 492 shares at $64.7465 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001610717-26-000393 · filed 2026-08-28 · View filing →

SEC FORM 4
$35,189.23

10x Genomics, Inc. (TXG)

Sale of 561 shares at $62.7259 per share.

Reporting Person SULIMAN SHEHNAAZ · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001610717-26-000389 · filed 2026-08-26 · View filing →

SEC FORM 4
$105,288.69

10x Genomics, Inc. (TXG)

Sale of 1,646 shares at $63.9664 per share.

Reporting Person SULIMAN SHEHNAAZ · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001610717-26-000389 · filed 2026-08-26 · View filing →

SEC FORM 4
$870,860.10

10x Genomics, Inc. (TXG)

Sale of 13,818 shares at $63.0236 per share.

Reporting Person Hindson Benjamin J. · Officer Title See Remarks · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001610717-26-000390 · filed 2026-08-26 · View filing →

SEC FORM 4
$1,081,852.82

10x Genomics, Inc. (TXG)

Sale of 17,166 shares at $63.0230 per share.

Reporting Person Taich Adam · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001610717-26-000391 · filed 2026-08-26 · View filing →

SEC FORM 4
$1,168,774.52

10x Genomics, Inc. (TXG)

Sale of 18,545 shares at $63.0237 per share.

Reporting Person Saxonov Serge · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001610717-26-000392 · filed 2026-08-26 · View filing →

SEC FORM 4
$129,901.95

10x Genomics, Inc. (TXG)

Sale of 2,273 shares at $57.15 per share.

Reporting Person Teichmann Sarah A. · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001610717-26-000359 · filed 2026-08-17 · View filing →

SEC FORM 4
$302,376.62

10x Genomics, Inc. (TXG)

Sale of 5,278 shares at $57.29 per share.

Reporting Person Teichmann Sarah A. · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001610717-26-000359 · filed 2026-08-17 · View filing →

SEC FORM 4
$978,880.40

10x Genomics, Inc. (TXG)

Sale of 17,000 shares at $57.5812 per share.

Reporting Person STUELPNAGEL JOHN R · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001610717-26-000358 · filed 2026-08-13 · View filing →

SEC FORM 4
$176,175.00

10x Genomics, Inc. (TXG)

Sale of 3,000 shares at $58.725 per share.

Reporting Person STUELPNAGEL JOHN R · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001610717-26-000358 · filed 2026-08-13 · View filing →